The Oklahoma Arthritis Center is pleased to announce the opening of the Oklahoma COVID Care Center.
The Oklahoma COVID Care Center is a stand-alone facility located in Edmond, OK dedicated to administering Eli Lilly’s bamlanivimab and Regeneron’s casirivimab / imdevimab COVID-19 infusion therapies under Emergency Use Authorization (EUA) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19).
These two therapies are monoclonal antibodies (mAbs) intended to directly neutralize the COVID-19 virus and prevent progression of the disease.
The COVID Care Center will infuse these therapies in adults and pediatric patients with a positive COVID-19 test, and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
For additional information, please call 405-726-9859 and ask to speak with one of our infusion coordinators or look us up on www.okcovidcare.com.
